G9018 Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)
Short descriptor: Zanamivir,inhalation pwd 10m
Look up G9018 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
G9018 is the HCPCS Level II code for Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project) (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Priced by carriers (physician fee schedule).
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Priced by carriers (physician fee schedule) (indicator 13)
- Type of Service
- Medical care
- Effective Date
- 2020-01-01
- Termination Date
- 2019-12-31
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference G9018 with the canonical source and edition:
G9018 — Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project). ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G9018
Canonical URL: https://icd10codingpro.com/hcpcs-codes/G9018